Overview of the pathogenesis of acne

Acne and its Therapy

Volumn , Issue , 2007, Pages 1-7

  Webster, Guy F ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 42649095462     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (55)

1. Kligman AM. An overview of acne. J Invest Dermatol 1974; 62:268–287.
2. Blair C, Lewis CA. The pigment of comedones. Br J Dermatol 1970; 82:572–583.
3. Marks R, Dawber RPR. Skin surface biopsy: an improved technique for examination of the horny layer. Br J Dermatol 1971; 84:117–123.
4. Knutson DD. Ultrastructural observations in acne vulgaris: the normal sebaceous follicle and acne lesions. J Invest Dermatol 1974; 62:288–307.
5. Leyden JJ, Kligman AM. Hairs in acne comedones. Arch Dermatol 1972; 106:851–853.
6. Kaidbey KH, Kligman AM. A human model for coal tar acne. Arch Dermatol 1974; 109:212–215.
7. Morris WE, Kwan SC. Use of the rabbit ear model in evaluating the comedogenic potential of cosmetic ingredients. J Soc Cosmet Chem 1983; 34:215–225.
8. Kligman AM, Kowng T. An improved rabbit ear model for assessing comedogenic substances. Br J Dermatol 1979; 100:699–702.
9. Izumi A, Marples RR, Kligman AM. Senile comedones. J Invest Dermatol 1973; 61:46–50.
10. Mills OH, Kligman AM. Comedogenicity of sunscreens. Arch Dermatol 1982; 118: 417–419.
11. Mills OH, Porte M, Kligman AM. Enhancement of comedogenic substances by ultraviolet readiation. Br J Dermatol 1978; 98:145–150.
12. Deyoung LM, Spires DA, Ballaron SJ. Acne like chronic inflammatory activity of Propionibacterium acnes preparations in an animal model. J Invest dermatol 1985; 85: 255–258.
13. Guy R, Kealey T. The effects of inflammatory cytokines on the isolated human sebaceous epithelium. J Invest Dermatol 1998; 110:410–415.
14. Guy R, Green MR, Kealey T. Modeling acne invitro. J Invest Dermatol 1996; 106: 176–182.
15. Lavker RM, Leyden JJ, McGinley KJ. The relationship between bacteria and the abnormal follicular keratinization in acne vulgaris. J Invest Dermatol 1981; 77:325–330.
16. Morello AM, Downing DT, Strauss JS. Octadecaenoic acids in the skin surface lipids of acne patients and normal controls. J Invest Dermatol 1976; 66:319–332.
17. Leyden JJ, McGinley KJ, Webster GF. Cutaneous bacteriology. In: Goldsmith L, ed. The Physiology and Biochemistry of the Skin. London: Oxford Press, 1983:1153–1165.
18. Marples RR, Downing DT, Kligman AM. Control of free fatty acids in skin surface lipid by Corynebacterium acnes. J Invest Dermatol 1971; 56:127–131.
19. McGinley KJ, Webster GF, Leyden JJ. Regional variations of cutaneous propionibacteria. Appl Environ Microbiol 1978; 35:62–66.
20. McGinley KJ, Webster GF, Ruggieri MR, Leyden JJ. Regional variations of cutaneous propionibacteria, correlation of Propionibacterium acnes populations with sebaceous secretion. J Clin Microbiol 1980; 12:672–675.
21. Speert DP, Wannamaker LW, Gray ED, Clawson CC. Related articles, Bactericidal effect of oleic acid on group A streptococci: mechanism of action. Infect Immun 1979; 26(3):1202–1210.
22. Webster GF, Ruggieri MR, McGinley KJ. Correlation of Propionibacterium acnes populations with the presence of triglycerides on non-human skin. Appl Environ Microbiol 1981; 41:1269–1270.
23. Cunliffe WJ, Perera WDH, Thackray P. Pilosebaceous duct physiology III. Observations on the number and size of pilosebaceous ducts in acne vulgaris. Br J Dermatol 1970; 82:572–583.
24. Leyden JJ, McGinley KJ, Mills OH, Kligman AM. Propionibacterium levels in patients with and without acne vulgaris. J Invest Dermatol 1975; 65:382–384.
25. Pochi P, Strauss JS, Rao RS. Plasma testosterone and sebum production in males with acne vulgaris. J Clin Endocrinol Metab 1965; 51:287–291.
26. Webster GF, Kligman AM. A method for the assay of inflammatory mediators in follicular casts. J Invest Dermatol 1979; 73:266–268.
27. Cummins CS, Johnson JL. Corynebacterium parvum: a synonym for Propionibacterium acnes? J Gen Microbiol 1974; 80(2):433–442.
28. Webster GF, Leyden JJ, Tsai C-C. Characterization of serum independent polymorphonuclear leukocyte chemotactic factors produced by Propionibacterium acnes. Inflammation 1980; 4:261–271.
29. Puhvel SM, Sakamoto M. Cytotoxin production by comedonal bacteria. J Invest Dermatol 1978; 71:324–329.
30. Lee WL, Shalita AR, Sunthralingam K. Neutrophil chemotaxis to P. acnes lipase and its inhibition. Infect Immun 1982; 35:71–78.
31. Webster GF, Leyden JJ, Nilsson UR. Complement activation by in acne vulgaris, consumption of complement by comedones. Infect Immun 1979; 26:186–188.
32. Leeming JP, Ingham E, Cunliffe WJ. Microbial contents and complement C3 cleaving activity of comedones in acne vulgaris. Acta Derm Venereol 1988; 68:469–473.
33. Webster GF, Nilsson UR, McArthur WR. Activation of the alternative pathway of complement by Propionibacterium acnes cell fractions. Inflammation 1981; 5:165–176.
34. Webster GF, McArthur WR. Activation of components of the alternative pathway of complement by Propionibacterium acnes cell wall carbohydrate. J Invest Dermatol 1982; 79:137–140.
35. Cummins CS, Linn DM. Related articles. Reticulostimulating properties of killed vaccines of anaerobic coryneforms and other organisms. J Natl Cancer Inst 1977; 59(6):1697–1708.
36. Webster GF, Leyden JJ, Norman ME, Nilsson UR. Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes and Propionibacterium granulosum. Infect Immun 1978; 22:523–529.
37. Vowels BR, Yang S, Leyden JJ. Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes implications for chronic inflammatory acne. Infect Immun 2000; 63:3158–3165.
38. Kim J, Ochoa M-T, Krutzik SR, et al. Activation of toll-like receptor 2 in acne tiggers inflammatory cytokine responses. J Immunol 2002; 169:1535–1541.
39. Norris JFB, Cunliffe WJ. A histological and immunocytochemical study of early acne lesions. Br J Dermatol 1988; 118:651–659.
40. Lavker RM, Leyden JJ, Kligman AM. The anti-inflammatory activity of isotretinoin is a major factor in the clearing of acne conglobata. In Marks R, Plewig G, eds. Acne and Related Disorders. London: Dunitz, 1989:207–216.
41. Sadler TE, Crump WA, Castro JE. Radiolabelling of Corynebacterium parvum and its distribution in mice. Br J Cancer 1977; 35:357–368.
42. Dimitrov NV, Greenberg CS, Denny T. Organ distribution of Corynebacterium parvum labeled with I-125. J Nat Canc Inst 1977; 58:287–294.
43. Webster GF, Leyden JJ, Musson RA, Douglas SD. Susceptibility of Propionibacterium acnes to killing and degradation by human monocytes and neutrophils in vitro. Infect Immun 1985; 49:116–121.
44. Marynick SP, Chakmakjian ZH, McCaffree DL, Herndon JH. Androgen excess in cystic acne. N Engl J Med 1983; 308:981–986.
45. Vexiau P, Husson C, Chivot M. Androgen excess in women with acne alone compared to women with acne and or hirsuitism. J Invest Derm 1990; 94:279–283.
46. Steinberger E, Smith KD, Rodrigues-Ridau LJ. Testosterone, dehydroepiandrosterone and dehydroepiandrosterone sulfate in hyperandrogenic women. J Clin Endocrinol Metab 1984; 59:47–477.
47. Nader S, Rodriguez-Rigau LJ, Smith KD, Sternberger E. Acne and hyperandrogenism. Impact of lowering androgen levels with glucocorticoid treatment. J Am Acad Derm 1984; 11:256–259.
48. Puhvel SM, Barfatani M, Warnick M. Study of antibody levels to Corynebacterium acnes. Arch Derm 1964; 90:421–427.
49. Puhvel SM, Hoffamn CK, Sternberg TH. Presence of complement fixing antibodies to Corynebacterium acnes in the sera of acne patients. Arch Derm 1966; 93:364–368.
50. Webster GF, Indrisano JP, Leyden JJ. Antibody titers to Propionibacterium acnes cell wall carbohydrate in nodulocystic acne patients. J Invest Derm 1985; 84:496–500.
51. Holland KT, Holland DB, Cunliffe WJ, Cutcliffe AG. Detection of Propionibacterium acnes polypeptides which have stimulated an immune response in acne patients but not in normal individuals. Exp Derm 1993; 2:12–16.
52. Puhvel SM, Amirian DA, Weintraub J. Lymphocyte transformation in subjects with nodulocystic acne. Br J Derm 1977; 97:205–210.
53. Gowland G, Ward RM, Holland KT, Cunliffe WJ. Cellular immunity to P. acnes in the normal population and in patients with acne. Br J Derm 1978; 99:43–48.
54. Kersey P, Sussman M, Dabl M. Delayed skin test reactivity to P. acnes correlates with the severity of inflammation in acne vulgaris. Br J Derm 1980; 103:651–655.
55. Webster GF, Leyden JJ, Tsai CC, McArthur WP. Polymorphonuclear leukocyte lysosomal enzyme release in response to Propionibacterium acnes in vitro and its enhancement by sera from patients with inflammatory acne. J Invest Der 1980; 74:398–401.